Advanced Search
LI Yuan, SONG Lihua, SONG Xianrang. Detection of ProGRP mRNA in Peripheral Blood and Its Signifi cance in Patients with Small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(04): 358-361. DOI: 10.3971/j.issn.1000-8578.2014.04.016
Citation: LI Yuan, SONG Lihua, SONG Xianrang. Detection of ProGRP mRNA in Peripheral Blood and Its Signifi cance in Patients with Small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(04): 358-361. DOI: 10.3971/j.issn.1000-8578.2014.04.016
shu

Detection of ProGRP mRNA in Peripheral Blood and Its Signifi cance in Patients with Small Cell Lung Cancer

  • 1.Department of Internal Medicine Oncology, Shandong Cancer Hospital, Shandong Academy of Medical Sciences, Ji'nan 250117, China; 2.School of Medicine and Life Sciences, University of Ji'nan, Shandong Academy of Medical Sciences; 3.Department of Oncology Hematology, Linyi People's Hospital; 4.Cancer Research Center, Shandong Cancer Hospital

More Information
  • Received Date: January 31, 2013
  • Revised Date: April 17, 2013
    Graphical Abstract
    • Abstract
  • Objective To investigate the relationship between the expression of pro-gastrin-releasing peptide(ProGRP) mRNA in peripheral blood and serum ProGRP protein and their association with pathological factors and chemotherapy response in patients with small cell lung cancer(SCLC). Methods The expression of ProGRP mRNA was detected by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) in peripheral blood from 61 patients with SCLC before the first and the third chemotherapy. Serum ProGRP protein was also determined by enzyme linked immunosorbent assay (ELISA). Results ProGRP mRNA expression and the level of serum ProGRP protein were related to primary tumor size, clinical stages and distant metastasis(P<0.05). Linear correlation analysis revealed then there was a correlation between ProGRP mRNA expression in peripheral blood and serum ProGRP protein level (R2=0.34, P<0.05). Both levels of ProGRP mRNA and serum ProGRP protein in PR and CR cases were signifi cantly declined following the second cycle of chemotherapy (P<0.05). There was no obvious decrease in SD and PD cases before or after treatment (P>0.05). Conclusion ProGRP mRNA could be used as a marker in the detection of circulating tumor cells in SCLC, and regular quantifi cation of ProGRP mRNA in peripheral blood may be useful to evaluate the therapeutic effi ciency and predict prognosis of SCLC patients. Serum ProGRP may also serve as a prognostic marker and be used in the assessment of therapeutic response in SCLC patients and the method is simple and feasible.
    • FullText(HTML)
    • References (10)
  • [1]
    Naito T, Tanaka F, Ono A, et al. Prognostic impact of circulating tumor cells in patients with small cell lung cancer [J]. J Thorac Oncol, 2012,7(3):512-9.
    [2]
    Hiltermann TJ, Pore MM, van den Berg A, et al. Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor[J].Ann Oncol, 2012,23 (11):2937-42.
    [3]
    Saito T, Kobayashi M, Harada R, et al. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin- releasing peptide mRNA [J]. Cancer, 2003, 97(10):2504-11.
    [4]
    Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) [J]. Eur J Cancer, 2009, 45(2): 228-47.
    [5]
    Tanaka F, Yoneda K, Kondo N, et al. Circulating tumor cell as a diagnostic marker in primary lung cancer [J]. Clin Cancer Res, 20 09, 15(22):6980-6.
    [6]
    Hou JM, Greystoke A, Lancashire L,et al. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy [J].Am J Pathol, 20 09, 175(2):808-16.
    [7]
    Ono A, Naito T, Ito I, et al. Correlations between serial progastrin- releasing peptide and neuron-specifi c enolase levels, and the radiological response to treatment and survival of patients with small-cell lung cancer[J].Lung Cancer,2012,76(3):439-44.
    [8]
    Yang HJ, Gu Y, Chen C, et al. Diagnostic value of pro-gastrinreleasing peptide for small cell lung cancer: a meta-analysis[J]. Clin Chem Lab Med,2011,49(6): 1039-46.
    [9]
    Hou JM, Krebs MG, Lancashire L,et al. Clinical signifi cance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer[J]. J Clin Oncol, 2012, 30(5):525-32.
    [10]
    Wu C, Hao H, Li L,et al. Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients [J]. J Thorac Oncol, 2009, 4(1):30-6.
    • Related Articles

  • Related Articles

    [1]KONG Yan, DONG Qian, LI Shuguang, XU Jinrui, ZHAO Xiaohan, DENG Wenzhao, SHEN Wenbin. Influence of Local Tumor Factors and Radiotherapy Dose on Prognosis of Clinical Stage T1-4N0M0 Esophageal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2025, 52(3): 225-232. DOI: 10.3971/j.issn.1000-8578.2025.24.0721
    [2]XIA Lili, ZHU Xinyi, ZHANG Xiwei, LI Zhengjiang, LIU Shaoyan, LU Haizhen, AN Changming. Predictive Value of Depth of Invasion of Tongue Squamous Cell Carcinoma for Cervical Lymph Node Metastasis and Prognosis[J]. Cancer Research on Prevention and Treatment, 2022, 49(7): 675-681. DOI: 10.3971/j.issn.1000-8578.2022.21.1460
    [3]LI Haiyan, ZHOU Xuan, CHEN Yunqing, JI Huihui, SHI Weiping, WANG Chengqin, XIANG Fenggang. Expression of KIF3A in Different Gastric Mucosal Lesions, Metastatic Lymph Nodes and Its Relationship with Metastasis and Prognosis of Gastric Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2018, 45(12): 985-990. DOI: 10.3971/j.issn.1000-8578.2018.18.0627
    [4]ZHAO Ruihua, JIANG Wenjing, ZHANG Weijie, CAO Xinguang. Metastasis?associated Lung Adenocarcinoma Transcript1(MALAT1) Expression in Middle Thoracic Esophageal Squamous Cell Cancer Tissues and Its Relationship with Prognosis[J]. Cancer Research on Prevention and Treatment, 2015, 42(12): 1227-1230. DOI: 10.3971/j.issn.1000-8578.2015.12.012
    [5]LV Minhao, QIN Li, LI Juntao, GUO Xuhui, LIU Fawen, CUI Shude, ZHANG Hengwei. 原发性乳腺癌分子分型与新辅助化疗疗效及预后的相关性[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 782-788. DOI: 10.3971/j.issn.1000-8578.2015.08.007
    [6]Zhen Chanjun, Zhou Zhiguo, Song Yuzhi, Qiao Xueying. Analysis of Therapeutic Effect and Prognosis of Radiotherapy for Patients with Esophageal Carcinoma with Supraclavicular Lymph Node Metastasis[J]. Cancer Research on Prevention and Treatment, 2013, 40(01): 90-94. DOI: 10.3971/j.issn.1000-8578.2013.01.023
    [7]LI Na, LI Shan-shan, ZHANG Hong-yan, XUAN Xiao-yan, ZHENG Xian-zhao, WANG Feng, YAN Ai-hua. Effects of KISS-1 Transfection on Tumor Growth of Nude Mice[J]. Cancer Research on Prevention and Treatment, 2010, 37(02): 136-140. DOI: 10.3971/j.issn.1000-8578.2010.02.004
    [8]LI Na, LI Shan-shan, ZHANG Hong-yan, XUAN Xiao-yan, ZHENG Xian-zhao, WANG Feng, YAN Ai-hua. Construction of Eukaryotic Expression Plasmid pcDNA3.1-KISS-1 and Its Metastasis Inhibiting Effect to EC1 Cells[J]. Cancer Research on Prevention and Treatment, 2009, 36(04): 265-269. DOI: 10.3971/j.issn.1000-8578.2009.04.002
    [9]GAO Zhao-hua. Analysis of Clinicopathologic Characteristics and Prognosis of Colorectal Cancer without Lymph Node Metastasis[J]. Cancer Research on Prevention and Treatment, 2008, 35(04): 272-274. DOI: 10.3971/j.issn.1000-8578.2697
    [10]Huang jinqiu, . The significance of tumor angiogenesis in the invasion metastasis and judging the prognosis of gastric carcinoma[J]. Cancer Research on Prevention and Treatment, 1998, 25(6): 441-444.

Catalog

    Get Citation
    PDF
    XML
    Article views (1382) PDF downloads (664) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Download Center

    Links

    Contact Us

    Address：116 Zhuodaoquan South Road,
    Hongshan District, Wuhan（430079）

    Tel：027－87670126

    Email：zlfzyjzz@vip.163.com

    This work is licensed under a Creative Commons Attribution 3.0 License.

    Email Alert RSS
    Total visits：12105691 Visits today：2320

    Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return